Churn in FDA’s in­spec­tion unit; Roche’s chang­ing of the guard; Il­lu­mi­na on de­fense; NASH be­liev­er finds new chal­lenge; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We wel­comed two new mem­bers to the ed­i­to­r­i­al team last week: Jared Whit­lock joined as fea­tures ed­i­tor while Aayushi Prat­ap came on board as a news re­porter. You might have read some of Aayushi’s news sto­ries al­ready, and Jared put out his first End­points In Fo­cus piece this week, on Il­lu­mi­na’s co­nun­drum. It’s an in­ter­est­ing read — check it out be­low.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.